Amlodipine interactions
Pro Research Analysisby 
Searched over 200M research papers for "amlodipine interactions"
Amlodipine Interactions: A Comprehensive Overview
Introduction to Amlodipine Interactions
Amlodipine, a widely used calcium channel blocker, is often prescribed for hypertension and angina. However, its interactions with other drugs can significantly impact its pharmacokinetics and pharmacodynamics. This article synthesizes recent research on amlodipine interactions with various drugs, highlighting key findings and clinical implications.
Amlodipine and Bisoprolol: Monitoring Liver Enzymes and Triglycerides
A study on the interaction between S-amlodipine and bisoprolol in healthy Chinese subjects found no significant pharmacokinetic interaction between the two drugs. However, there was a notable increase in liver enzymes (alanine aminotransferase and aspartate aminotransferase) and triglycerides, suggesting the need for close monitoring of these parameters during co-administration .
Amlodipine and Tadalafil: Increased Tadalafil Concentration
When amlodipine is combined with tadalafil, a phosphodiesterase-5 inhibitor, there is a significant increase in tadalafil's concentration. The geometric mean ratios for tadalafil's AUC and Cmax were 1.57 and 1.34, respectively. Despite this interaction, the combination was well tolerated, with no significant increase in adverse events compared to monotherapy .
Amlodipine, Valsartan, and Rosuvastatin: Decreased Valsartan Exposure
Research involving the co-administration of amlodipine, valsartan, and rosuvastatin showed a decrease in valsartan exposure, while the pharmacokinetics of amlodipine and rosuvastatin remained unchanged. This suggests that while amlodipine and rosuvastatin can be safely combined, the reduced efficacy of valsartan should be considered .
Amlodipine and Lobeglitazone: No Significant Interaction
A study on the interaction between amlodipine and lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, found no significant pharmacokinetic interactions. Both drugs maintained their pharmacokinetic profiles when administered together, indicating that they can be co-administered without dose adjustments .
Amlodipine and Atorvastatin: Effective Combination Therapy
The Respond trial evaluated the combination of amlodipine and atorvastatin in patients with hypertension and dyslipidemia. The study found that the combination effectively reduced systolic blood pressure and low-density lipoprotein cholesterol without adverse pharmacodynamic interactions, making it a viable option for managing multiple cardiovascular risk factors .
Amlodipine, Valsartan, and Hydrochlorothiazide: No Clinically Relevant Interactions
A study assessing the pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide found no clinically relevant interactions. The combination therapy was well tolerated, with no significant changes in the pharmacokinetic parameters of each drug .
Amlodipine, Telmisartan, and Rosuvastatin: Increased Rosuvastatin and Telmisartan Exposure
When co-administered with telmisartan and rosuvastatin, amlodipine did not alter its pharmacokinetic profile. However, there was an increase in the exposure of rosuvastatin and telmisartan, which, although not clinically significant, should be considered in clinical practice .
Amlodipine and Quercetin: Competitive Binding to Human Serum Albumin
A study on the interaction between amlodipine and quercetin, a plant flavonoid, revealed that quercetin can displace amlodipine from its binding site on human serum albumin. This competitive interaction suggests that co-administration of these compounds could affect the pharmacokinetics of amlodipine .
Amlodipine and Antibiotics: Increased Bioavailability
Research on the interaction between amlodipine and antibiotics, specifically ampicillin, showed that antibiotics could increase the bioavailability of amlodipine by suppressing gut microbial metabolism. This interaction highlights the need for caution and clinical monitoring when these drugs are co-administered .
Conclusion
Amlodipine interacts with various drugs, affecting its pharmacokinetics and pharmacodynamics. While some combinations, like amlodipine with atorvastatin, are effective and well-tolerated, others require careful monitoring of liver enzymes, triglycerides, and drug concentrations. Understanding these interactions is crucial for optimizing therapeutic outcomes and minimizing adverse effects.
Sources and full results
Most relevant research papers on this topic